Émilie Jouanjus - Concepedia

Author

Émilie Jouanjus

Inserm ORCID

Also Known As

E. Jouanjus, Emilie Jouanjus, Istvan Marion, Jouanjus, Emilie, Marylène Guerlais, Émilie Jouanjus

103

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Inserm Université Fédérale de Toulouse Midi-Pyrénées Université Toulouse III - Paul Sabatier Centre Hospitalier Universitaire de Toulouse Aix-Marseille Université

ÉJ

About

Émilie Jouanjus is an author at Inserm specializing in addiction, substance abuse, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	245
2	Health Sciences	5	5	161
3	Public Health	2	2	73
4	Social Sciences	2	2	38
5	Anesthesia	1	1	12

Émilie Jouanjus

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders Émilie Jouanjus, Maryse Lapeyre‐Mestre, Joëlle Micallef Journal of the American Heart Association	2014	248
Cannabis‐related hospitalizations: unexpected serious events identified through hospital databases Émilie Jouanjus, F. Leymarie, M. Tubéry, British Journal of Clinical Pharmacology	2010	111
Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France Damien Driot, Émilie Jouanjus, Stéphane Oustric, British Journal of Clinical Pharmacology	2019	103
The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database Marion Robert, Émilie Jouanjus, Charles Khouri, Addiction	2022	71
Signal Identification in Addictovigilance: the Functioning of the French System Émilie Jouanjus, Valérie Gibaja, Jean‐Pierre Kahn, Therapies Substance AbuseBehavioral SciencesSubstance UseSignal IdentificationPsychoactive Drug	2015	67
Medical prescriptions falsified by the patients: a 12‐year national monitoring to assess prescription drug diversion Émilie Jouanjus, Grégory Guernec, Maryse Lapeyre‐Mestre Fundamental and Clinical Pharmacology	2018	58
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance Marine Tambon, Camille Ponté, Émilie Jouanjus, Frontiers in Psychiatry	2021	58
Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database Jean‐Baptiste Bossard, Camille Ponté, Julie Dupouy, Clinical Drug Investigation Drug SafetySubstance AbuseDisproportionality AnalysisPsychiatryAddiction	2016	42
Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns—A cohort study Julie Dupouy, Jean‐Pascal Fournier, Émilie Jouanjus, European Neuropsychopharmacology Substance AbuseAlcohol MisuseSubstance UsePsychiatryTreated Patients	2013	40
Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting François Montastruc, Haleh Bagheri, Isabelle Lacroix, Drug Safety Drug SafetyDrug InteractionsTherapeutic Drug MonitoringClassical MethodsMedicine	2017	40

Page 1